FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016508077> ?p ?o ?g. }

• W2016508077 endingPage "414" @default.
• W2016508077 startingPage "407" @default.
• W2016508077 abstract "The antimicrobial activity of cetylpyridinium chloride (CPC) and miramistin (MST) solutions at different concentrations (5×10(-5) to 0.4%) and a dressing, containing 0.15% CPC, were tested against Staphylococcus aureus, Pseudomonas aeruginosa and Escherichia coli after 30 (solutions) and 60 min (fleece) incubation, respectively. Furthermore, the cytotoxic effects of CPC and MST were examined in human keratinocyte (HaCaT) and murine fibroblast (L929) cell lines. A dose of 3×10(-3)% CPC or MST was sufficient to entirely eradicate S. aureus after 30 min incubation. To achieve the same effect, higher concentrations were required against E. coli (0.025% CPC; 0.0125% MST) and P. aeruginosa (0.5% CPC; 0.05% MST). The CPC-fleece showed a high antiseptic effect against all three bacterial strains, although it did not completely eliminate P. aeruginosa. Both substances showed a high cytotoxic impact at higher tested concentrations (CPC >3×10(-3)%; MST >8×10(-4)%). CPC showed high antimicrobial potency at low concentrations against S. aureus, accompanied by low cytotoxic (side) effects at these concentrations, whilst the required minimal concentration to eradicate E. coli and P. aeruginosa was shown to be cytotoxic for keratinocytes and fibroblasts. The necessary antibacterial amounts of MST were lower, but also cytotoxic in direct contact with typical human wound cells. With regard to demographic changes and increasing bacterial resistance, new effective antiseptics, such as CPC and MST, incorporated in wound dressings without releasing an active substance could help to improve the treatment and healing rates of chronic wounds." @default.
• W2016508077 created "2016-06-24" @default.
• W2016508077 creator A5011893460 @default.
• W2016508077 creator A5023317947 @default.
• W2016508077 creator A5048583375 @default.
• W2016508077 creator A5053080233 @default.
• W2016508077 creator A5059964139 @default.
• W2016508077 date "2015-04-01" @default.
• W2016508077 modified "2023-09-30" @default.
• W2016508077 title "Cetylpyridinium chloride and miramistin as antiseptic substances in chronic wound management – prospects and limitations" @default.
• W2016508077 cites W1417735314 @default.
• W2016508077 cites W1517708538 @default.
• W2016508077 cites W1966439045 @default.
• W2016508077 cites W1982001036 @default.
• W2016508077 cites W1990369653 @default.
• W2016508077 cites W2021910827 @default.
• W2016508077 cites W2027202317 @default.
• W2016508077 cites W2036564087 @default.
• W2016508077 cites W2037634970 @default.
• W2016508077 cites W2039154211 @default.
• W2016508077 cites W2056064788 @default.
• W2016508077 cites W2066869553 @default.
• W2016508077 cites W2083162734 @default.
• W2016508077 cites W2090872736 @default.
• W2016508077 cites W2109603174 @default.
• W2016508077 cites W2120883121 @default.
• W2016508077 cites W2127343455 @default.
• W2016508077 cites W2140227020 @default.
• W2016508077 cites W2161952512 @default.
• W2016508077 cites W2400125958 @default.
• W2016508077 cites W4243531908 @default.
• W2016508077 cites W4255462926 @default.
• W2016508077 doi "https://doi.org/10.1099/jmm.0.000034" @default.
• W2016508077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25681322" @default.
• W2016508077 hasPublicationYear "2015" @default.
• W2016508077 type Work @default.
• W2016508077 sameAs 2016508077 @default.
• W2016508077 citedByCount "44" @default.
• W2016508077 countsByYear W20165080772016 @default.
• W2016508077 countsByYear W20165080772017 @default.
• W2016508077 countsByYear W20165080772018 @default.
• W2016508077 countsByYear W20165080772019 @default.
• W2016508077 countsByYear W20165080772020 @default.
• W2016508077 countsByYear W20165080772021 @default.
• W2016508077 countsByYear W20165080772022 @default.
• W2016508077 countsByYear W20165080772023 @default.
• W2016508077 crossrefType "journal-article" @default.
• W2016508077 hasAuthorship W2016508077A5011893460 @default.
• W2016508077 hasAuthorship W2016508077A5023317947 @default.
• W2016508077 hasAuthorship W2016508077A5048583375 @default.
• W2016508077 hasAuthorship W2016508077A5053080233 @default.
• W2016508077 hasAuthorship W2016508077A5059964139 @default.
• W2016508077 hasBestOaLocation W20165080771 @default.
• W2016508077 hasConcept C104317684 @default.
• W2016508077 hasConcept C109316439 @default.
• W2016508077 hasConcept C118995209 @default.
• W2016508077 hasConcept C154317977 @default.
• W2016508077 hasConcept C176947019 @default.
• W2016508077 hasConcept C178790620 @default.
• W2016508077 hasConcept C185592680 @default.
• W2016508077 hasConcept C202751555 @default.
• W2016508077 hasConcept C2777637488 @default.
• W2016508077 hasConcept C2778206598 @default.
• W2016508077 hasConcept C2779489039 @default.
• W2016508077 hasConcept C2781460226 @default.
• W2016508077 hasConcept C4937899 @default.
• W2016508077 hasConcept C523546767 @default.
• W2016508077 hasConcept C54355233 @default.
• W2016508077 hasConcept C547475151 @default.
• W2016508077 hasConcept C55493867 @default.
• W2016508077 hasConcept C58226133 @default.
• W2016508077 hasConcept C86803240 @default.
• W2016508077 hasConcept C89423630 @default.
• W2016508077 hasConceptScore W2016508077C104317684 @default.
• W2016508077 hasConceptScore W2016508077C109316439 @default.
• W2016508077 hasConceptScore W2016508077C118995209 @default.
• W2016508077 hasConceptScore W2016508077C154317977 @default.
• W2016508077 hasConceptScore W2016508077C176947019 @default.
• W2016508077 hasConceptScore W2016508077C178790620 @default.
• W2016508077 hasConceptScore W2016508077C185592680 @default.
• W2016508077 hasConceptScore W2016508077C202751555 @default.
• W2016508077 hasConceptScore W2016508077C2777637488 @default.
• W2016508077 hasConceptScore W2016508077C2778206598 @default.
• W2016508077 hasConceptScore W2016508077C2779489039 @default.
• W2016508077 hasConceptScore W2016508077C2781460226 @default.
• W2016508077 hasConceptScore W2016508077C4937899 @default.
• W2016508077 hasConceptScore W2016508077C523546767 @default.
• W2016508077 hasConceptScore W2016508077C54355233 @default.
• W2016508077 hasConceptScore W2016508077C547475151 @default.
• W2016508077 hasConceptScore W2016508077C55493867 @default.
• W2016508077 hasConceptScore W2016508077C58226133 @default.
• W2016508077 hasConceptScore W2016508077C86803240 @default.
• W2016508077 hasConceptScore W2016508077C89423630 @default.
• W2016508077 hasIssue "4" @default.
• W2016508077 hasLocation W20165080771 @default.
• W2016508077 hasLocation W20165080772 @default.
• W2016508077 hasOpenAccess W2016508077 @default.
• W2016508077 hasPrimaryLocation W20165080771 @default.

• next